Dr. Yasmin Thanavala on targeted therapy for liver cancer
2 vistas
• 06/28/23
0
0
Empotrar
administrator
Suscriptores
Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios